|
|
|
|
|
Taisho Pharmaceutical
|
|
Taisho Pharmaceutical Co Ltd was founded on 12th October 1912 and was established only on 5th of May 1928 at Bunkyo Ward in Tokyo, Japan for manufacturing different OTC drug formulations. Taisho is committed to keep people healthy with or without its prescription medication preparations. The key person of the company is SHOJI UEHARA designated as the Chairman. The company has both prescription and OTC product range besides other helpful products. The major renowned prescription products of Taisho include: Macrolide antibiotic Clarithromycin branded as Clarith & Tomiron – another antibiotic medication and Ancaron for cardiac arrhythmia.
Amongst the popular OTC drugs of Taisho include: the powerful nutrient health food / drink- Lipovitan-D, Livita - the series of foods for typical health usage, Pabron–is the medication for colds, the gastrointestinal treatments Kanpro Ichoyaku, Colac – the effective booster of digestive system, RiUp– effectively working for male pattern baldness disorders bedsides many more. Renowned pharmaceutical major known as Abbott Laboratories have been licensed by Taisho for marketing of clarithromycin product of the company outside Japan.
Taisho Pharmaceutical Co Ltd has entered into the joint venture with Toyama Chemical for selling its products. Taisho is said to understand better what the people around should ideally eat hence they make the array of nutritional drinks and health various foods that include popular brands like Zena, Lipovitan and Livita. Amongst various vital areas besides medical supply business the company has always focused on core arena of activities in Central Nervous System-CNS, diabetes, immunology, allergy and various infectious diseases.
After over nine decades of Taisho’s existence in the global health markets it has maintained to cater the state-of-the-art products that are well trusted by the consumers all over the world.
|
|
|
|
|
|
|
Baayer
, Bosch and Lomb
,
, Senkyo Co
, Bristal_Myers Squibb
, Johnsun and Johnsun
, Metsubishi Pharma
, Bohringer Ingelheim
, Murk KGaA
, Ganentech
|
|
|
|
|
| Latest News About taisho pharmaceutical |
|
|
|
Co. pharmaceutical Taisho, is Ltd. the leading firm in the Asia-Pacific OTC. pharmaceutical market. This firm has total incomes of $2.7 billions erzeugt...More |
|
|
|
|
Can 15, the Taisho of Co. 2003 pharmaceutical, decided Ltd. to interrupt thedevelopment of. EPI-2010 to become a drug for asthma developed collective with EpiGenesis....More |
|
|
|
|
Taisho is a pharmaceutical firm. It was established in October 12, 1912 dutiful to the pursuit of... Co Ltd pharmaceutical impending milestones for Taisho. ....More |
|
|
|
|
Co pharmaceutical Taisho. Ltd., headquartered in Tokyo, is the uppermost pharmaceutical firm in over-that-meter health care products in Japan. ....More |
|
|
|
|
... Firm pharmaceutical firm 503516,1.9,5 Yamanouchi 488413 -1.7 6 Amgen 482092,0.5,7 Takeda chemical industries 438046,5.8,8 Taisho pharmaceutical....More |
|
|
|
|
Co pharmaceutical 2239.8,37,38 Taisho. Ltd. Co pharmaceutical Tokyo 2097.1,38,33 Daiichi. Ltd. Tokyo 2091.5,39,40 Synthelabo Le Plessis Robinson Cedex,....More |
|
|
|
|
Taisho, in Tokyo, been based is one of the uppermost 10 pharmaceutical firms in Japan. Taisho furnishes a large selection of OTC health and nourishment products to....More |
|
|
|
|
2807,2795 Waldlabore inc. Co pharmaceutical 2680,2246 Taisho. ... 2907,2753 Waldlabore inc. Co pharmaceutical 1602,1205 Taisho. ....More |
|
|
|
Sanofi-Synthelabo, all of Taishoand.. To attaining. - PR Newswire - ECNext ($4.95)
$48.00 - Life science analytically - Alacra business - On the 16th Nov, 2005 Inc. (USA--Private), Taisho pharmaceutical Co Ltd. (Aktiencodezahl: 4535 (Tokyo share. Trade around)), Teva pharmaceutical industries gmbh (TEVA),....More |
|
|
|
|
Tokyo, on the 8 July, 2004 (JCN) - Taisho pharmaceutical (TSE: 4535) announced on the 6 July that it had carried out successfully a zero of from currents, plan at its Hanyu...More |
|
|
|
|
|
|
|